OSD
For drug development companies balancing time, formulation trends and changing technologies are just some of the hurdles to overcome in order to get a medicine to market. The process can be complex and require a high level of expertise to ensure success and consistent pharmacokinetic (PK) profiles.
In this interview with Outsourcing Pharma our Sales Director, Mikael Bisrat discusses the challenges facing drug development companies and how these can be offset by contract development and manufacturing organisations (CDMOs).
The biggest challenge is often ensuring that limited time, effort and resources are spent developing a suitable formulation for Phase 1, and at the same time ensure that these results pave the way for further development into Phase II/III.